These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 7487618)

  • 1. Effects of brimonidine on aqueous humor dynamics in human eyes.
    Toris CB; Gleason ML; Camras CB; Yablonski ME
    Arch Ophthalmol; 1995 Dec; 113(12):1514-7. PubMed ID: 7487618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients.
    Toris CB; Camras CB; Yablonski ME
    Am J Ophthalmol; 1999 Jul; 128(1):8-14. PubMed ID: 10482088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of apraclonidine on aqueous humor dynamics in human eyes.
    Toris CB; Tafoya ME; Camras CB; Yablonski ME
    Ophthalmology; 1995 Mar; 102(3):456-61. PubMed ID: 7891985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aqueous humor flow in normal human eyes treated with brimonidine and timolol, alone and in combination.
    Larsson LI
    Arch Ophthalmol; 2001 Apr; 119(4):492-5. PubMed ID: 11296014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the early effects of brimonidine and apraclonidine as topical ocular hypotensive agents.
    Maus TL; Nau C; Brubaker RF
    Arch Ophthalmol; 1999 May; 117(5):586-91. PubMed ID: 10326954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of travoprost on aqueous humor dynamics in patients with elevated intraocular pressure.
    Toris CB; Zhan G; Fan S; Dickerson JE; Landry TA; Bergamini MV; Camras CB
    J Glaucoma; 2007 Mar; 16(2):189-95. PubMed ID: 17473728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daytime and nighttime effects of brimonidine on IOP and aqueous humor dynamics in participants with ocular hypertension.
    Fan S; Agrawal A; Gulati V; Neely DG; Toris CB
    J Glaucoma; 2014; 23(5):276-81. PubMed ID: 24886701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes.
    Toris CB; Camras CB; Yablonski ME
    Ophthalmology; 1993 Sep; 100(9):1297-304. PubMed ID: 8371915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aqueous humor flow in normal human eyes treated with brimonidine and dorzolamide, alone and in combination.
    Tsukamoto H; Larsson LI
    Arch Ophthalmol; 2004 Feb; 122(2):190-3. PubMed ID: 14769595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy of apraclonidine and brimonidine as aqueous suppressants in humans.
    Schadlu R; Maus TL; Nau CB; Brubaker RF
    Arch Ophthalmol; 1998 Nov; 116(11):1441-4. PubMed ID: 9823343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of Latanoprost 0.005% on aqueous humor flow and outflow facility in glaucoma patients: a double-masked placebo-controlled clinical study.
    Dinslage S; Hueber A; Diestelhorst M; Krieglstein G
    Graefes Arch Clin Exp Ophthalmol; 2004 Aug; 242(8):654-60. PubMed ID: 15241610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of travoprost on aqueous humor dynamics in monkeys.
    Toris CB; Zhan GL; Camras CB; McLaughlin MA
    J Glaucoma; 2005 Feb; 14(1):70-3. PubMed ID: 15650608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in outflow facility with unoprostone treatment in ocular hypertensive patients.
    Toris CB; Zhan G; Camras CB
    Arch Ophthalmol; 2004 Dec; 122(12):1782-7. PubMed ID: 15596580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diurnal and nocturnal variations in aqueous humor dynamics of patients with ocular hypertension undergoing medical therapy.
    Gulati V; Fan S; Zhao M; Maslonka MA; Gangahar C; Toris CB
    Arch Ophthalmol; 2012 Jun; 130(6):677-84. PubMed ID: 22332206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of topical epinephrine on aqueous humor dynamics in the cat.
    Wang YL; Toris CB; Zhan G; Yablonski ME
    Exp Eye Res; 1999 Apr; 68(4):439-45. PubMed ID: 10192801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and mechanisms of intraocular pressure reduction with latanoprost and timolol in participants with ocular hypertension: a comparison of 1 and 6 weeks of treatment.
    Johnson TV; Fan S; Zhan G; Camras CB; Toris CB
    J Glaucoma; 2010 Aug; 19(6):356-64. PubMed ID: 20179619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover study.
    Lim KS; Nau CB; O'Byrne MM; Hodge DO; Toris CB; McLaren JW; Johnson DH
    Ophthalmology; 2008 May; 115(5):790-795.e4. PubMed ID: 18452763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 8-iso prostaglandin E2 on aqueous humor dynamics in monkeys.
    Wang RF; Lee PY; Mittag TW; Podos SM; Serle JB; Becker B
    Arch Ophthalmol; 1998 Sep; 116(9):1213-6. PubMed ID: 9747682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group.
    Schuman JS; Horwitz B; Choplin NT; David R; Albracht D; Chen K
    Arch Ophthalmol; 1997 Jul; 115(7):847-52. PubMed ID: 9230823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of brimonidine 0.2% in controlling acute postoperative intraocular pressure elevation after phacoemulsification.
    Katsimpris JM; Siganos D; Konstas AG; Kozobolis V; Georgiadis N
    J Cataract Refract Surg; 2003 Dec; 29(12):2288-94. PubMed ID: 14709288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.